M&P Pharma Services Ltd 14220514 false 2023-08-01 2024-07-31 2024-07-31 The principal activity of the company is investment holding company. Digita Accounts Production Advanced 6.30.9574.0 true true 14220514 2023-08-01 2024-07-31 14220514 2024-07-31 14220514 bus:OrdinaryShareClass1 bus:Non-cumulativeNon-redeemableShares 2024-07-31 14220514 bus:OrdinaryShareClass2 bus:Non-cumulativeNon-redeemableShares 2024-07-31 14220514 bus:OrdinaryShareClass3 bus:Non-cumulativeNon-redeemableShares 2024-07-31 14220514 bus:OrdinaryShareClass4 bus:Non-cumulativeNon-redeemableShares 2024-07-31 14220514 bus:OrdinaryShareClass5 bus:Non-cumulativeNon-redeemableShares 2024-07-31 14220514 core:FinancialAssetsDesignatedFairValueThroughProfitOrLoss core:Non-currentFinancialInstruments 2024-07-31 14220514 core:CurrentFinancialInstruments 2024-07-31 14220514 core:CurrentFinancialInstruments core:WithinOneYear 2024-07-31 14220514 core:Non-currentFinancialInstruments 2024-07-31 14220514 core:Non-currentFinancialInstruments core:AfterOneYear 2024-07-31 14220514 bus:SmallEntities 2023-08-01 2024-07-31 14220514 bus:AuditExemptWithAccountantsReport 2023-08-01 2024-07-31 14220514 bus:FilletedAccounts 2023-08-01 2024-07-31 14220514 bus:SmallCompaniesRegimeForAccounts 2023-08-01 2024-07-31 14220514 bus:RegisteredOffice 2023-08-01 2024-07-31 14220514 bus:Director1 2023-08-01 2024-07-31 14220514 bus:Director2 2023-08-01 2024-07-31 14220514 bus:OrdinaryShareClass1 bus:Non-cumulativeNon-redeemableShares 2023-08-01 2024-07-31 14220514 bus:OrdinaryShareClass2 bus:Non-cumulativeNon-redeemableShares 2023-08-01 2024-07-31 14220514 bus:OrdinaryShareClass3 bus:Non-cumulativeNon-redeemableShares 2023-08-01 2024-07-31 14220514 bus:OrdinaryShareClass4 bus:Non-cumulativeNon-redeemableShares 2023-08-01 2024-07-31 14220514 bus:OrdinaryShareClass5 bus:Non-cumulativeNon-redeemableShares 2023-08-01 2024-07-31 14220514 bus:PrivateLimitedCompanyLtd 2023-08-01 2024-07-31 14220514 countries:AllCountries 2023-08-01 2024-07-31 14220514 2022-07-07 2023-07-31 14220514 2023-07-31 14220514 bus:OrdinaryShareClass1 bus:Non-cumulativeNon-redeemableShares 2023-07-31 14220514 bus:OrdinaryShareClass2 bus:Non-cumulativeNon-redeemableShares 2023-07-31 14220514 bus:OrdinaryShareClass3 bus:Non-cumulativeNon-redeemableShares 2023-07-31 14220514 bus:OrdinaryShareClass4 bus:Non-cumulativeNon-redeemableShares 2023-07-31 14220514 bus:OrdinaryShareClass5 bus:Non-cumulativeNon-redeemableShares 2023-07-31 14220514 core:CurrentFinancialInstruments 2023-07-31 14220514 core:CurrentFinancialInstruments core:WithinOneYear 2023-07-31 14220514 core:Non-currentFinancialInstruments 2023-07-31 14220514 core:Non-currentFinancialInstruments core:AfterOneYear 2023-07-31 14220514 bus:OrdinaryShareClass3 bus:Non-cumulativeNon-redeemableShares 2022-07-07 2023-07-31 14220514 bus:OrdinaryShareClass4 bus:Non-cumulativeNon-redeemableShares 2022-07-07 2023-07-31 14220514 bus:OrdinaryShareClass5 bus:Non-cumulativeNon-redeemableShares 2022-07-07 2023-07-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 14220514

M&P Pharma Services Ltd

Unaudited Filleted Financial Statements

for the Year Ended 31 July 2024

 

M&P Pharma Services Ltd

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

4 to 6

 

M&P Pharma Services Ltd

Company Information

Directors

M Bridgewater

P W J Bridgewater

Registered office

The Willows
Heathwood Road
Higher Heath
Whitchurch
Shropshire
SY13 2HG

Accountants

CBSL Accountants Limited
Chartered Accountants
Rowan House North
1 The Professional Quarter
Shrewsbury Business Park
Shrewsbury
Shropshire
SY2 6LG

 

M&P Pharma Services Ltd

(Registration number: 14220514)
Balance Sheet as at 31 July 2024

Note

2024
£

(As restated)

2023
£

Fixed assets

 

Other financial assets

4

1,495,454

-

Current assets

 

Debtors

5

-

100

Cash at bank and in hand

 

106,597

-

 

106,597

100

Creditors: Amounts falling due within one year

6

(858)

-

Net current assets

 

105,739

100

Total assets less current liabilities

 

1,601,193

100

Creditors: Amounts falling due after more than one year

6

(1,601,169)

-

Net assets

 

24

100

Capital and reserves

 

Called up share capital

7

400

100

Retained earnings

(376)

-

Shareholders' funds

 

24

100

For the financial year ending 31 July 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

 

M&P Pharma Services Ltd

(Registration number: 14220514)
Balance Sheet as at 31 July 2024

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 2 April 2025 and signed on its behalf by:
 

M Bridgewater
Director

 

M&P Pharma Services Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2024

1

General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
The Willows
Heathwood Road
Higher Heath
Whitchurch
Shropshire
SY13 2HG

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 0 (2023 - 0).

 

M&P Pharma Services Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2024

4

Other financial assets (current and non-current)

Financial assets at fair value through profit and loss
£

Total
£

Non-current financial assets

Cost or valuation

Fair value adjustments

9,975

9,975

Additions

1,485,479

1,485,479

At 31 July 2024

1,495,454

1,495,454

Carrying amount

At 31 July 2024

1,495,454

1,495,454

At 31 July 2024 the cost of the financial asset investments was £1,485,479.

5

Debtors

Current

2024
£

(As restated)

2023
£

Other debtors

-

100

 

-

100

 

M&P Pharma Services Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2024

6

Creditors

Creditors: amounts falling due within one year

2024
£

2023
£

Due within one year

Accruals and deferred income

858

-

Creditors: amounts falling due after more than one year

Note

2024
£

2023
£

Due after one year

 

Loans and borrowings

8

1,601,169

-

7

Share capital

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

A Ordinary of £1 each

50

50

50

50

B Ordinary of £1 each

50

50

50

50

C Ordinary of £1 (2023 - £0) each

100

100

-

-

D Ordinary of £1 (2023 - £0) each

100

100

-

-

E Ordinary of £1 (2023 - £0) each

100

100

-

-

400

400

100

100

8

Loans and borrowings

Non-current loans and borrowings

2024
£

2023
£

Other borrowings

1,601,169

-

9

Related party transactions

Other transactions with directors

At 31 July 2024 the company owed a balance of £1,601,169, which is included in Other borrowings due after more than one year.